Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 8/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 8/20 | 0.36 |
| ▸ | TAS1R2 | Q8TE23 | 8/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | MMP3 | P08254 | 2/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18855074 | 0.97 | TAS1R3 (0.38) | TAS1R3TAS1R1TAS1R2CTSS | |
| SCHEMBL12411251 | 0.92 | CTSS (0.36) | CTSSMMP2MMP3MMP1 | |
| SCHEMBL15185807 | 0.92 | CTSS (0.36) | CTSSMMP2MMP3MMP1 | |
| SCHEMBL14949074 | 0.80 | CTSS (0.37) | TAS1R3TAS1R1TAS1R2CTSSMMP2 | |
| SCHEMBL25908942 | 0.74 | TAS1R3 (0.37) | TAS1R3TAS1R1TAS1R2CTSSMMP2 | |
| SCHEMBL19361698 | 0.71 | HDAC3 (0.34) | — | |
| SCHEMBL13254073 | 0.71 | OPRM1 (0.37) | — | |
| SCHEMBL26428476 | 0.71 | OPRM1 (0.37) | — | |
| SCHEMBL23306946 | 0.69 | TRPA1 (0.45) | CTSS | |
| SCHEMBL25462622 | 0.69 | ALDH1A1 (0.43) | CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362275-A1 | Growth Hormone Releasing Peptides | IPSEN PHARMA S.A.S. (FR) | 2017-12-21 | — | — | US | disclosed |
| US-20160311855-A1 | Growth Hormone Releasing Peptides | IPSEN PHARMA S.A.S. (FR) | 2016-10-27 | — | — | US | disclosed |
| US-9475837-B2 | Process for the synthesis of therapeutic peptides | IPSEN MANUFACTURING IRELAND LIMITED (IE) | 2016-10-25 | — | — | US | disclosed |
| US-20150045534-A1 | Process for the Synthesis of Therapeutic Peptides | IPSEN MANUFACTURING IRELAND LIMITED (IE) | 2015-02-12 | — | — | US | disclosed |
| US-8859729-B2 | Growth hormone releasing peptides | IPSEN PHARMA S.A.S. (FR) | 2014-10-14 | — | — | US | disclosed |
| US-20130210751-A1 | Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands | IPSEN PHARMA, S.A.S. (FR) | 2013-08-15 | — | — | US | disclosed |
| US-20130123170-A1 | Growth Hormone Releasing Peptides | IPSEN PHARMA, S.A.S. (FR) | 2013-05-16 | — | — | US | disclosed |
| US-8377865-B2 | Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders | IPSEN PHARMA S.A.S. (FR) | 2013-02-19 | — | — | US | disclosed |
| US-7456253-B2 | Peptidomimetics; determining ability to bind growth hormone secretagogue; ghrelin agonists; appetite stimulation; dietetics | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, SAS (FR) | 2008-11-25 | — | — | US | disclosed |
| US-20080242619-A1 | Growth hormone releasing peptides | BIOMEASURE, INCORPORATED | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311855-A1 | Growth Hormone Releasing Peptides | GHRHR, THRB, PRLHR | TAS1R3 1838/4885TAS1R1 2209/4885TAS1R2 2259/4885 |
| US-20080242619-A1 | Growth hormone releasing peptides | GHRHR, THRB, PRLHR | TAS1R3 1586/4885TAS1R1 1904/4885TAS1R2 1984/4885 |
| US-20150045534-A1 | Process for the Synthesis of Therapeutic Peptides | MAX, VIP, SFPQ | TAS1R3 2143/4885TAS1R1 2591/4885TAS1R2 2451/4885 |
| US-20130123170-A1 | Growth Hormone Releasing Peptides | GHRHR, THRB, PRLHR | TAS1R3 1838/4885TAS1R1 2209/4885TAS1R2 2259/4885 |
| US-20130210751-A1 | Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands | GHSR, GHRHR, SSTR5 | TAS1R3 1242/4885TAS1R1 1039/4885TAS1R2 1199/4885 |
| US-20170362275-A1 | Growth Hormone Releasing Peptides | GHRHR, THRB, PRLHR | TAS1R3 1838/4885TAS1R1 2209/4885TAS1R2 2259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.